C-CUBE builds its first large modular vaccine facility in Europe

C-CUBE has installed modules directly outdoors, encompassing both the facility and the cleanroom area of its first large modular vaccine facility build in Europe.

The Singapore-based company specialises in modular facilities for the life sciences and its smart Cleanroom Modules are self-sufficient and suitable for installation into any existing infrastructure.

The cleanroom modules can also stand alone as a facility and the facility will still be Current Good Manufacturing Practices (cGMP) compliant.

Modular vaccine facilities are designed for flexibility, enabling quicker construction and operation compared to traditional facilities.

C-Cube’s innovation could enhance vaccine manufacturing capacity in Europe and support rapid responses to pandemics and other health crises.

“This success is setting the stage for rapid growth and development in the coming years. I would like to extend my heartfelt gratitude to all the companies and individuals who have supported us throughout this journey, helping to turn our vision into a remarkable reality,” Co-Founder & CEO  of C-CUBE, Christophe Mermaz, posted on LinkedIn.